Crossmark

Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study

Crossref DOI link: https://doi.org/10.1186/s13063-018-2803-4

Published Online: 2018-08-04

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Prout, Hayley C. http://orcid.org/0000-0003-0170-7027
Barham, Allan

Bongard, Emily

Tudor-Edwards, Rhiannon

Griffiths, Gareth

Hamilton, Willie

Harrop, Emily

Hood, Kerry

Hurt, Chris N.

Nelson, Rosie

Porter, Catherine

Roberts, Kirsty

Rogers, Trevor

Thomas-Jones, Emma

Tod, Angela

Yeo, Seow Tien

Neal, Richard D.

Nelson, Annmarie
License Information

Text and Data Mining valid from 2018-08-04
More Information

Article History

Received: 10 April 2017

Accepted: 10 July 2018

First Online: 4 August 2018

Ethics approval and consent to participate

: NHS ethics was approved by the North Wales Research Ethics Committee (11/WA/022) on the 25 August 2011. This included the qualitative substudy for all the centres involved. We also obtained informed consent from each participant recruited into the study.

: This qualitative study used anonymized quotes from study participants. Participants consented to their anonymized quotes being reported.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.